RhumbLine Advisers’s Perspective Therapeutics CATX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $286K | Sell |
83,250
-14,912
| -15% | -$51.3K | ﹤0.01% | 3011 |
|
|
2025
Q1 | $209K | Buy |
98,162
+3,170
| +3% | +$6.75K | ﹤0.01% | 3082 |
|
|
2024
Q4 | $303K | Buy |
94,992
+4,075
| +4% | +$13K | ﹤0.01% | 2979 |
|
|
2024
Q3 | $1.21M | Buy |
90,917
+27,747
| +44% | +$370K | ﹤0.01% | 2164 |
|
|
2024
Q2 | $630K | Buy |
+63,170
| New | +$630K | ﹤0.01% | 2508 |
|